Revenue | Over $500 million See Exact Annual Revenue |
---|---|
Employees | Over 1,000Exact Company Size |
Primary Industry | 5411 Legal Services |
Additional NAICS Codes | 54138 Testing Laboratories |
Address | 251 Ballardvale St Wilmington, MA 01887 |
Charles River Laboratories | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | Over $500 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
Trademark | Date |
---|---|
TUMBLER Scientific and technological services, namely, scientific research, analysis and testing and the development of technology in the field of medicine and pharmaceuticals and research activities relating thereto; research and development and consultation related thereto in the field of antibody development; scientific research services, namely, antibody engineering for analytical and clinical purposes; antibody engineering; custom design and engineering of antibodies; research services using a platform of biological research tools and techniques to speed development of antibodies; providing access to a proprietary technology platform containing antibodies that gives users the ability to obtain information for research purposes | 11/21/2023 |
TUNGSTEN Research and development services in the field of antibodies; antibody discovery services; scientific and technological services and research projects in relation to screening of antibody libraries, namely, in the field of antibody discovery for scientific research services; medical and scientific research for the identification, preparation, and development of phage and antibody libraries; scientific and technological services and research projects for the preparation, identification and characterization of antibodies, namely, scientific research and analysis in the field of antibody research and antibody optimization; research and development of new products featuring a synthetic antibody library including methods for selection and screening of such; scientific and technological services and research projects in relation to batch-cloning and screening of natural, engineered and immunized libraries, namely, scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of antibody libraries, namely, scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to the optimization, maturation and humanization of antibody drug candidates, namely, scientific research and analysis in the field of antibody research and drug design | 11/21/2023 |
SUPERHUMAN Research and development services in the field of antibodies; antibody discovery services; scientific and technological services and research projects in relation to screening of antibody libraries, namely, in the field of antibody discovery for scientific research services; medical and scientific research for the identification, preparation, and development of phage and antibody libraries; scientific and technological services and research projects for the preparation, identification and characterization of antibodies, namely, scientific research and analysis in the field of antibody research and antibody optimization; research and development of new products featuring a synthetic antibody library including methods for selection and screening of such; scientific and technological services and research projects in relation to batch-cloning and screening of natural, engineered and immunized libraries, namely, scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of antibody libraries, namely, scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to the optimization, maturation and humanization of antibody drug candidates, namely, scientific research and analysis in the field of antibody research and drug design | 11/21/2023 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
AUSTIN 316 FIDUCIARY LIMITED | Oceanside, NY | 100 |
CONSILIO | Washington, DC | 66 |
LATHAM & WATKINS | Los Angeles, CA | 54 |
KIRKLAND & ELLIS | Chicago, IL | 49 |
CO STATE FRATERNAL ORDER OF POLICE | Westminster, CO | 44 |
GREENBERG TRAURIG P.A. | Miami, FL | 42 |
PROFESSIONAL LAW ENFORCEMENT A | Rochester, MI | 38 |
CHG COMPANIES | Midvale, UT | 35 |
BAKER & MCKENZIE | Chicago, IL | 33 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
ZWICKER & ASSOCIATES P.C | Andover, MA | 100 |
FIREMEN & OILERS CH3 LOC 615 SEIU SUB GRP LEG SERV FUND | Woburn, MA | 22 |
KORDE & ASSOCIATES P.C. | Lowell, MA | 13 |
DALTON & FINEGOLD | Andover, MA | 6 |
NORTHEAST LEGAL AID | Lawrence, MA | 5 |
FOSTER & ELDRIDGE | Woburn, MA | 5 |
Company | Revenue ($ MM) |
---|---|
![]() |